fludarabine has been researched along with Edema in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Sharkawi, D; Stewart, A; Williams, R | 1 |
| Adams, EM; Bartlett, ML; Fleisher, T; Hicks, JE; McGarvey, C; Plotz, PH; Pucino, F; Sonies, BC; Thornton, B; Villalba, ML; Yarboro, C | 1 |
1 trial(s) available for fludarabine and Edema
| Article | Year |
|---|---|
A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures.
Topics: Adult; Aged; Anti-Inflammatory Agents; Dermatomyositis; Edema; Female; Flow Cytometry; Hematologic Tests; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Pilot Projects; Polymyositis; Prednisone; Treatment Outcome; Vidarabine | 1999 |
1 other study(ies) available for fludarabine and Edema
| Article | Year |
|---|---|
Systemic capillary leak syndrome: a rare but potentially life-threatening cause of protein loss and oedema in B cell prolymphocytic leukaemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capillary Leak Syndrome; Cyclophosphamide; Edema; Humans; Hypoalbuminemia; Leukemia, Prolymphocytic, B-Cell; Male; Middle Aged; Rituximab; Serum Albumin, Human; Treatment Outcome; Vidarabine | 2020 |